Atomo Diagnostics Limited (ASX:AT1)
Australia
· Delayed Price · Currency is AUD 0.0190
-0.0010 (-5.00%)
Apr 24, 2025, 12:47 PM AEST
Atomo Diagnostics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2017 - 2019 |
| Revenue | 4.22 | 4.09 | 2.54 | 12.34 | 6.72 | 5.37 | Upgrade
|
| Revenue Growth (YoY) | 35.63% | 60.65% | -79.38% | 83.69% | 25.09% | 894.69% | Upgrade
|
| Cost of Revenue | 2.74 | 2.65 | 3.05 | 8.45 | 3.63 | 1.95 | Upgrade
|
| Gross Profit | 1.48 | 1.44 | -0.5 | 3.88 | 3.09 | 3.42 | Upgrade
|
| Selling, General & Admin | 4.71 | 5.3 | 6.57 | 7.3 | 6.16 | 4.3 | Upgrade
|
| Research & Development | 0.41 | 0.24 | 0.6 | 1.41 | 0.82 | 0.7 | Upgrade
|
| Other Operating Expenses | 0.87 | 0.9 | 1.16 | -1.73 | 0.2 | -0.04 | Upgrade
|
| Operating Expenses | 7.61 | 8.1 | 10.23 | 8.98 | 8.49 | 5.64 | Upgrade
|
| Operating Income | -6.14 | -6.66 | -10.73 | -5.1 | -5.41 | -2.22 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -8.26 | Upgrade
|
| Interest & Investment Income | 0.11 | 0.15 | 0.07 | 0.01 | 0.09 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | 0.03 | 0.11 | 0.09 | -0.41 | -0.56 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.38 | 0.44 | 0.6 | -0.69 | -0.4 | 1.8 | Upgrade
|
| EBT Excluding Unusual Items | -5.66 | -6.05 | -9.96 | -5.71 | -6.13 | -9.22 | Upgrade
|
| Asset Writedown | -0.8 | -0.8 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.11 | - | Upgrade
|
| Pretax Income | -6.45 | -6.85 | -9.96 | -5.71 | -6.02 | -9.22 | Upgrade
|
| Net Income | -6.45 | -6.85 | -9.96 | -5.71 | -6.02 | -9.22 | Upgrade
|
| Net Income to Common | -6.45 | -6.85 | -9.96 | -5.71 | -6.02 | -9.22 | Upgrade
|
| Shares Outstanding (Basic) | 640 | 635 | 571 | 569 | 564 | 355 | Upgrade
|
| Shares Outstanding (Diluted) | 640 | 635 | 571 | 569 | 564 | 355 | Upgrade
|
| Shares Change (YoY) | 6.66% | 11.17% | 0.34% | 0.82% | 58.81% | 27.47% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 | -0.03 | Upgrade
|
| Free Cash Flow | -3.59 | -4.7 | -5.91 | -4.2 | -7.35 | -7.08 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | Upgrade
|
| Gross Margin | 35.09% | 35.16% | -19.71% | 31.47% | 45.96% | 63.68% | Upgrade
|
| Operating Margin | -145.54% | -162.94% | -421.68% | -41.30% | -80.50% | -41.37% | Upgrade
|
| Profit Margin | -153.10% | -167.57% | -391.46% | -46.26% | -89.66% | -171.70% | Upgrade
|
| Free Cash Flow Margin | -85.05% | -115.06% | -232.25% | -34.04% | -109.37% | -131.89% | Upgrade
|
| EBITDA | -5.17 | -5.42 | -9.25 | -3.63 | -4.46 | -1.65 | Upgrade
|
| EBITDA Margin | -122.66% | -132.72% | - | -29.45% | -66.36% | -30.70% | Upgrade
|
| D&A For EBITDA | 0.96 | 1.24 | 1.48 | 1.46 | 0.95 | 0.57 | Upgrade
|
| EBIT | -6.14 | -6.66 | -10.73 | -5.1 | -5.41 | -2.22 | Upgrade
|
| EBIT Margin | -145.54% | -162.94% | - | -41.30% | -80.50% | -41.37% | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.